- Home
- REPL vs BKSY Comparison
REPL vs BKSY Comparison
Compare REPL & BKSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- BKSY
- Stock Information
- Founded
- REPL 2015
- BKSY 2013
- Country
- REPL United States
- BKSY United States
- Employees
- REPL N/A
- BKSY N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- BKSY Radio And Television Broadcasting And Communications Equipment
- Sector
- REPL Health Care
- BKSY Technology
- Exchange
- REPL Nasdaq
- BKSY Nasdaq
- Market Cap
- REPL 547.0M
- BKSY 643.3M
- IPO Year
- REPL 2018
- BKSY N/A
- Fundamental
- Price
- REPL $5.71
- BKSY $19.16
- Analyst Decision
- REPL Hold
- BKSY Strong Buy
- Analyst Count
- REPL 9
- BKSY 6
- Target Price
- REPL $7.00
- BKSY $23.50
- AVG Volume (30 Days)
- REPL 2.1M
- BKSY 1.6M
- Earning Date
- REPL 11-11-2025
- BKSY 11-06-2025
- Dividend Yield
- REPL N/A
- BKSY N/A
- EPS Growth
- REPL N/A
- BKSY N/A
- EPS
- REPL N/A
- BKSY N/A
- Revenue
- REPL N/A
- BKSY $104,662,000.00
- Revenue This Year
- REPL N/A
- BKSY $15.43
- Revenue Next Year
- REPL $408.25
- BKSY $34.03
- P/E Ratio
- REPL N/A
- BKSY N/A
- Revenue Growth
- REPL N/A
- BKSY N/A
- 52 Week Low
- REPL $2.68
- BKSY $3.86
- 52 Week High
- REPL $17.00
- BKSY $28.85
- Technical
- Relative Strength Index (RSI)
- REPL 46.92
- BKSY 56.84
- Support Level
- REPL $5.60
- BKSY $17.89
- Resistance Level
- REPL $6.15
- BKSY $19.88
- Average True Range (ATR)
- REPL 0.33
- BKSY 1.15
- MACD
- REPL 0.06
- BKSY 0.37
- Stochastic Oscillator
- REPL 32.48
- BKSY 84.13
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About BKSY BlackSky Technology Inc.
BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.